2. Dahlback B, Carlssou M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8. 3. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-93. 4. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6. 5. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22. 6. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7. 7. Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4. 8. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4. 9. Hakala L, Vahtera E, Krusius T, Rasi V. APC-resisteussi ja hyytymistekija V:n mutaatio suomalaisilla tromboosipotilailla (in Finnish). Duodecim 1995; 22: 2143-51. 10. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Brit J Ophthalmol 1996; 80: 200-2. 11. Williamson TH, Rumley A, Lowe GDO. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Brit J Ophthalmol 1996; 80: 203-8. 12. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6. 13. Engel H, Zwang L, van Vliet HHDM, Michiels JJ, Stibbe J, Lindemans J. Phenotyping and genotyping of coagulation factor V Leiden. Thromb Haemost 1996; 75: 267-9. 14. Alhadyan AA. Retinal vein occlusion in Saudi-Arabia: possible role of dehydration. Ann Ophthalmol 1993; 25: 394-8.
[1]
R. Magatelli,et al.
Prevalence of Mutant Factor V in Italian Patients with Hereditary Deficiencies of Antithrombin, Protein C or Protein S
,
1996,
Thrombosis and Haemostasis.
[2]
N. Dzimiri,et al.
World distribution of factor V Leiden
,
1996,
The Lancet.
[3]
J. Lindemans,et al.
Phenotyping and Genotyping of Coagulation Factor V Leiden
,
1996,
Thrombosis and Haemostasis.
[4]
A. Evans,et al.
Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance
,
1995,
The Lancet.
[5]
R. Bertina,et al.
Laboratory Diagnosis of APC-Resistance: A Critical Evaluation of the Test and the Development of Diagnostic Criteria
,
1994,
Thrombosis and Haemostasis.
[6]
P. Prandoni,et al.
Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance
,
1994,
Thrombosis and Haemostasis.
[7]
Pieter H. Reitsma,et al.
Mutation in blood coagulation factor V associated with resistance to activated protein C
,
1994,
Nature.
[8]
G. Leone,et al.
Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
,
1995,
Haematologica.